Lucid Diagnostics (LUCD) Preferred Dividend Payments (2024 - 2026)

Lucid Diagnostics (LUCD) posted Preferred Dividend Payments of $9.7 million for Q1 2026, up 177.39% on a QoQ basis from -$12.6 million in Q4 2025, and up 6.68% year-over-year from $9.1 million in Q1 2025.

Lucid Diagnostics (LUCD) Preferred Dividend Payments (2024 - 2026) Analysis & Trends

Lucid Diagnostics' Preferred Dividend Payments history runs 3 years deep, the most recent figure standing at $9.7 million for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Lucid Diagnostics 133.09 Mn 105.22 Mn -325,000.00 9.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.72 Mn
Dec 31, 2025 -12.56 Mn
Jun 30, 2025 3.45 Mn
Mar 31, 2025 9.11 Mn
Dec 31, 2024 -7.50 Mn
Mar 31, 2024 7.50 Mn